Cervidil
Drug Womens Health
NDC 55566-2800-1
General payments
$24,348
Research payments
$7,499
Through program year 2025, $24,348 in general payments and $7,499 in research payments were reported against Cervidil (Womens Health).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $382 | 5 |
| 2024 | General | $1,243 | 16 |
| 2023 | General | $785 | 10 |
| 2022 | General | $575 | 11 |
| 2021 | General | $98 | 5 |
| 2020 | General | $1,697 | 49 |
| 2019 | General | $19,568 | 505 |
| 2019 | Research | $7,499 | 1 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
601 general · 1 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.